Institutional Manager · CIK 0001381843
Atle Fund Management AB
STOCKHOLM, V7 · File #028-12171
Latest AUM
$313.4M
Positions
39
Top-10 Concentration
53.0%
Filings
8
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | CVS HEALTH CORP | CVS | +106,518 | +$8.5M | $0 |
| NEW | IONIS PHARMACEUTICALS INC | IONS | +92,377 | +$7.3M | $0 |
| NEW | INCYTE CORP | INCY | +70,851 | +$7.0M | $0 |
| REDUCE | Eli Lilly & Co | LLY | -6,111 | -$6.6M | +$37.0M |
| NEW | INSMED INC | INSM | +27,873 | +$4.9M | $0 |
| NEW | ABIVAX SA | AAVXF | +31,590 | +$4.3M | $0 |
| ADD | AbbVie Inc | ABBV | +16,076 | +$3.7M | +$18.8M |
| ADD | Merck & Co. Inc | MRK | +34,855 | +$3.7M | +$15.5M |
| NEW | IDEAYA BIOSCIENCES INC | IDYA | +97,438 | +$3.4M | $0 |
| REDUCE | Gilead Sciences Inc | GILD | -27,373 | -$3.4M | +$8.7M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202539 pos · $313.4M
- 13F HOLDINGS REPORTQ/E Sep 202538 pos · $27.0M
- 13F HOLDINGS REPORTQ/E Jun 202537 pos · $233.7M
- 13F HOLDINGS REPORTQ/E Mar 202537 pos · $226.5M
- 13F HOLDINGS REPORTQ/E Dec 202436 pos · $210.8M
- 13F HOLDINGS REPORTQ/E Sep 202436 pos · $212.8M
- 13F HOLDINGS REPORTQ/E Jun 202438 pos · $164.0M
- 13F HOLDINGS REPORTQ/E Mar 202444 pos · $164.4M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 31,133 | $33.5M | 10.67% |
| 2 | AbbVie Inc | ABBV | 108,181 | $24.7M | 7.89% |
| 3 | Merck & Co. Inc | MRK | 195,768 | $20.6M | 6.57% |
| 4 | Thermo Fisher Scientific Corp | TMO | 29,915 | $17.3M | 5.53% |
| 5 | Neurocrine Biosciences Inc | NBIX | 94,796 | $13.4M | 4.29% |
| 6 | Intuitive Surgical Inc | ISRG | 22,322 | $12.6M | 4.03% |
| 7 | BEONE MEDICINES LTD-ADR | BEIGF | 40,432 | $12.3M | 3.92% |
| 8 | Bridgebio Pharma Inc | BBIO | 141,296 | $10.8M | 3.45% |
| 9 | Vertex Pharmaceuticals Inc | VRTX | 22,984 | $10.4M | 3.32% |
| 10 | Boston Scientific Corp | BSX | 108,682 | $10.4M | 3.31% |
| 11 | Stryker Corporation | SYK | 26,835 | $9.4M | 3.01% |
| 12 | CVS HEALTH CORP | CVS | 106,518 | $8.5M | 2.70% |
| 13 | Krystal Biotech, Inc | KRYS | 33,853 | $8.3M | 2.66% |
| 14 | Cencora Inc | COR | 23,773 | $8.0M | 2.56% |
| 15 | IONIS PHARMACEUTICALS INC | IONS | 92,377 | $7.3M | 2.33% |
| 16 | REVOLUTION Medicines Inc | RVMDW | 90,184 | $7.2M | 2.29% |
| 17 | Amgen Inc | AMGN | 21,903 | $7.2M | 2.29% |
| 18 | Mirum Pharmaceuticals Inc | MIRM | 89,685 | $7.1M | 2.26% |
| 19 | INCYTE CORP | INCY | 70,851 | $7.0M | 2.23% |
| 20 | NewAmsterdam Pharma Co NV | NAMSW | 197,036 | $6.9M | 2.21% |